Issuer Information

EDGAR: Contact Information
  • Name:
    Petros Pharmaceuticals, Inc.
  • Address:
    1185 AVENUE OF THE AMERICAS
    3RD FLOOR
    NEW YORK, NEW YORK 10036
  • Phone:
    973-242-0005
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2020)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
490880: 0001104659-23-083066
First Sale: 2023-07-13
Security Type(s): Equity
Offer Amount: $30,000,006
Amount Sold: $30,000,006
06b

CT, NJ, NY,

424723: 0001104659-22-000473
First Sale: 2021-12-22
Security Type(s): Equity
Offer Amount: $8,324,820
Amount Sold: $2,200,023
Remaining: $6,124,797
06b

CT, DC, MA,

410470: 0001104659-21-146360
First Sale: 2021-11-29
Security Type(s): Equity
Offer Amount: $12,815,000
Amount Sold: $3,540,000
Remaining: $9,275,000
06b

CT, DC,

405202: 0001104659-21-129900
First Sale: 2021-10-13
Offer Amount: $5,922,951
Remaining: $5,922,951
06b

CT,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.